Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
113 studies found for:    Open Studies | "Vomiting"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Vomiting"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Evaluation of Predictive Risk Factors of Chemotherapy-induced Nausea and Vomiting
Condition: Chemotherapy-induced Nausea and Vomiting
Intervention:
2 Recruiting Aprepitant ,Olanzapine,Palonosetron and Dexamethasone for the Prevention of Chemotherapy-induced Nausea and Vomiting
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Olanzapine;   Drug: Aprepitant;   Drug: Palonosetron;   Drug: Dexamethasone
3 Not yet recruiting The Effect of Acupuncture in Chemotherapy-induced Nausea and Vomiting
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Other: Verum acupuncture and medicine;   Other: Sham acupuncture and medicine
4 Not yet recruiting Transcutaneous Electrical Acupoint Stimulation(TEAS) for Postoperative Nausea and Vomiting in Laparoscopic Operation
Condition: Postoperative Nausea and Vomiting
Intervention: Device: TEAS (transcutaneous electrical acupoint stimulation)
5 Recruiting Effect of Aromatherapy on Postoperative Nausea, Vomiting and Quality of Recovery
Condition: Postoperative Nausea and Vomiting
Interventions: Procedure: Lavender Aromatherapy;   Procedure: Rose Aromatherapy;   Procedure: Ginger Aromatherapy;   Procedure: Placebo Aromatherapy
6 Recruiting Postoperative Nausea and Vomiting: to Estimate the Incidence and Risk Factors in a Tertiary Teaching Hospital
Condition: Postoperative Nausea and Vomiting
Intervention:
7 Recruiting Sugammadex Versus Neostigmine for Postoperative Nausea and Vomiting After Laparoscopic Gynaecological Surgery
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: Neuromuscular reversal by Sugammadex;   Drug: Neuromuscular reversal by Neostigmine;   Drug: Atropine sulfate-diphenoxylate hydrochloride combination
8 Not yet recruiting Prophylactic Ondansetron in Post-op Cardiac Surgery Patients to Prevent Post-operative Nausea and Vomiting
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: Ondansetron;   Drug: Saline/Placebo
9 Recruiting Risk Factors for Postoperative Nausea/Vomiting
Condition: Postoperative Nausea and Vomiting
Intervention: Procedure: General anesthesia
10 Recruiting Gabapentin to Reduce Postoperative Nausea and Vomiting
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: Gabapentin;   Drug: Placebo
11 Recruiting Prospective Study of Palonosetron in Radiation Induced Nausea and Vomiting (RINV)
Conditions: Nausea;   Vomiting
Interventions: Drug: Palonosetron;   Radiation: Low or moderate risk radiotherapy
12 Recruiting Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis
Condition: Postoperative Nausea and Vomiting
Interventions: Procedure: Automated recommendation at the start of the case;   Procedure: Automated notification at the start of surgery;   Procedure: Preoperative recommendations: by email;   Procedure: Automated notification at the end of surgery;   Device: Anesthesia Information Management System (AIMS);   Device: Perioperative Data Warehouse (PDW);   Procedure: General anesthesia;   Procedure: Elective surgery;   Drug: Propofol;   Drug: Sevoflurane;   Drug: Isoflurane;   Drug: Desflurane;   Drug: Scopolamine;   Drug: Droperidol;   Drug: Haloperidol;   Drug: Dexamethasone;   Drug: Promethazine;   Drug: Meclizine;   Drug: Aprepitant;   Drug: Metoclopramide;   Drug: Fentanyl;   Drug: Sufentanil;   Drug: Alfentanil;   Drug: Remifentanil;   Drug: Morphine;   Drug: Meperidine;   Drug: Hydromorphone;   Drug: Methadone;   Drug: Oxycodone;   Drug: Oxymorphone;   Drug: Hydrocodone;   Drug: Ketamine;   Drug: Ondansetron;   Drug: Granisetron;   Drug: Dolasetron mesylate;   Drug: Palonosetron;   Drug: Tropisetron;   Drug: Ramosetron
13 Not yet recruiting Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Aprepitant+palonosetron+dexamethasone;   Drug: palonosetron+dexamethasone
14 Recruiting Granisetron Transdermal Patch for Prevention of Postoperative Nausea and Vomiting
Condition: Postoperative Nausea and Vomiting
Intervention: Drug: granisetron
15 Not yet recruiting Intraoperative Electronic Reminder Module to Enhance Postoperative Nausea and Vomiting Prophylaxis
Condition: Postoperative Nausea and Vomiting
Intervention: Other: Postoperative nausea and vomiting (PONV) reminder
16 Not yet recruiting Dexmedetomidine or Dexmedetomidine Combined With Dexamethasone on Postoperative Nausea and Vomiting in Breast Cancer
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: Dexmedetomidine;   Drug: Dexmedetomidine and dexamethasone;   Drug: Control
17 Not yet recruiting Intravenous Versus Intra-peritoneal Dexamethasone on the Incidence of Postoperative Nausea and Vomiting
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: Intravenous Dexamethasone;   Drug: Intraperitoneal Dexamesathone
18 Recruiting Compare Between Two Doses of Palonosetron on the Prevention of Postoperative Nausea and Vomiting in Obese Patients
Condition: Postoperative Nausea and Vomiting
Intervention: Drug: palonosetron
19 Not yet recruiting Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Vitrectomy Under Local Anesthesia
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: PLACEBO;   Drug: Dexamethasone;   Drug: Ondansetron;   Drug: Dexamethasone + Ondansetron
20 Recruiting Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients
Condition: Chemotherapy-induced Nausea and Vomiting
Intervention: Drug: Palonosetron, ondansetron, dexamethasone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.